{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:34:22Z","timestamp":1761766462223,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["KLI341"],"award-info":[{"award-number":["KLI341"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Paracelsus Medical University Salzburg","award":["A-14\/01\/010-BWA"],"award-info":[{"award-number":["A-14\/01\/010-BWA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0940-1","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T22:25:00Z","timestamp":1541024700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex"],"prefix":"10.1186","volume":"13","author":[{"given":"Michael","family":"Ablinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas K.","family":"Felder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Wimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Zauner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lettner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wolkersdorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian B.","family":"Lagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Diem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8705-3890","authenticated-orcid":false,"given":"Verena","family":"Wally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"940_CR1","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/nm1504","volume":"12","author":"F Mavilio","year":"2006","unstructured":"Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, Recchia A, et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med. 2006;12:1397\u2013402.","journal-title":"Nat Med"},{"key":"940_CR2","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1001\/jama.2016.15588","volume":"316","author":"Z Siprashvili","year":"2016","unstructured":"Siprashvili Z, Nguyen NT, Gorell ES, Loutit K, Khuu P, Furukawa LK, et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA. 2016;316:1808\u201317.","journal-title":"JAMA"},{"key":"940_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature24487","volume":"551","author":"T Hirsch","year":"2017","unstructured":"Hirsch T, Rothoeft T, Teig N, Bauer JW, Pellegrini G, De Rosa L, et al. Regeneration of the entire human epidermis using transgenic stem cells. Nature. 2017;551:327\u201332.","journal-title":"Nature"},{"key":"940_CR4","volume-title":"Epidermolysis Bullosa Simplex","author":"EG Pfendner","year":"1993","unstructured":"Pfendner EG, Bruckner AL. Epidermolysis Bullosa Simplex. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, Amemiya A, editors. . Seattle: GeneReviews\u00ae; 1993-2018."},{"key":"940_CR5","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jaad.2018.01.019","volume":"78","author":"V Wally","year":"2018","unstructured":"Wally V, Hovnanian A, Ly J, Buckova H, Brunner V, Lettner T, et al. Diacerein orphan drug development for epidermolysis bullosa simplex: a phase 2\/3 randomized, placebo-controlled, double-blind clinical trial. J Am Acad Dermatol. 2018;78:892\u2013901 e897.","journal-title":"J Am Acad Dermatol"},{"key":"940_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1750-1172-8-69","volume":"8","author":"V Wally","year":"2013","unstructured":"Wally V, Kitzmueller S, Lagler F, Moder A, Hitzl W, Wolkersdorfer M, et al. Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study. Orphanet J Rare Dis. 2013;8:69.","journal-title":"Orphanet J Rare Dis."},{"key":"940_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.abb.2010.12.019","volume":"508","author":"JC Chamcheu","year":"2011","unstructured":"Chamcheu JC, Siddiqui IA, Syed DN, Adhami VM, Liovic M, Mukhtar H. Keratin gene mutations in disorders of human skin and its appendages. Arch Biochem Biophys. 2011;508:123\u201337.","journal-title":"Arch Biochem Biophys"},{"key":"940_CR8","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/jid.2013.31","volume":"133","author":"V Wally","year":"2013","unstructured":"Wally V, Lettner T, Peking P, Peckl-Schmid D, Murauer EM, Hainzl S, et al. The pathogenetic role of IL-1beta in severe epidermolysis bullosa simplex. J Invest Dermatol. 2013;133:1901\u20133.","journal-title":"J Invest Dermatol"},{"key":"940_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2165\/00003088-199835050-00002","volume":"35","author":"P Nicolas","year":"1998","unstructured":"Nicolas P, Tod M, Padoin C, Petitjean O. Clinical pharmacokinetics of diacerein. Clin Pharmacokinet. 1998;35:347\u201359.","journal-title":"Clin Pharmacokinet"},{"key":"940_CR10","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.2174\/092986712803306358","volume":"19","author":"L Bartosova","year":"2012","unstructured":"Bartosova L, Bajgar J. Transdermal drug delivery in vitro using diffusion cells. Curr Med Chem. 2012;19:4671\u20137.","journal-title":"Curr Med Chem"},{"key":"940_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/bmc.977","volume":"22","author":"B Layek","year":"2008","unstructured":"Layek B, Kumar TS, Trivedi RK, Mullangi R, Srinivas NR. Development and validation of a sensitive LC-MS\/MS method with electrospray ionization for quantitation of rhein in human plasma: application to a pharmacokinetic study. Biomed Chromatogr. 2008;22:616\u201324.","journal-title":"Biomed Chromatogr"},{"key":"940_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030762","volume":"19","author":"B Liemberger","year":"2018","unstructured":"Liemberger B, Pinon Hofbauer J, Wally V, Arzt C, Hainzl S, Kocher T, et al. RNA trans-splicing modulation via antisense molecule interference. Int J Mol Sci. 2018;19:E762.","journal-title":"Int J Mol Sci"},{"key":"940_CR13","doi-asserted-by":"publisher","unstructured":"Peking P, Breitenbach JS, Ablinger M, Muss WH, Poetschke FJ, Kocher T et al. An ex-vivo RNA trans-splicing strategy to correct human generalized severe epidermolysis bullosa simplex. Br J Dermatol. 2018. doi: \n                    https:\/\/doi.org\/10.1111\/bjd.17075\n                    \n                  .","DOI":"10.1111\/bjd.17075"},{"key":"940_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.omtm.2017.06.008","volume":"6","author":"M Aushev","year":"2017","unstructured":"Aushev M, Koller U, Mussolino C, Cathomen T, Reichelt J. Traceless targeting and isolation of gene-edited immortalized keratinocytes from epidermolysis bullosa simplex patients. Mol Ther Methods Clin Dev. 2017;6:112\u201323.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"940_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0140-6736(89)90461-3","volume":"2","author":"P Humbert","year":"1989","unstructured":"Humbert P, Renaud A, Laurent R, Agache P. Tetracyclines for dystrophic epidermolysis bullosa. Lancet. 1989;2:277.","journal-title":"Lancet"},{"key":"940_CR16","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/j.1365-2133.2005.06492.x","volume":"152","author":"S Ozanic Bulic","year":"2005","unstructured":"Ozanic Bulic S, Fassihi H, Mellerio JE, McGrath JA, Atherton DJ. Thalidomide in the management of epidermolysis bullosa pruriginosa. Br J Dermatol. 2005;152:1332\u20134.","journal-title":"Br J Dermatol"},{"key":"940_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jaad.2015.04.015","volume":"73","author":"JD Fine","year":"2015","unstructured":"Fine JD, Manes B, Frangoul H. Systemic granulocyte colony-stimulating factor (G-CSF) enhances wound healing in dystrophic epidermolysis bullosa (DEB): results of a pilot trial. J Am Acad Dermatol. 2015;73:56\u201361.","journal-title":"J Am Acad Dermatol"},{"key":"940_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/bjd.13672","volume":"173","author":"C Chiaverini","year":"2015","unstructured":"Chiaverini C, Fontas E, Vabres P, Bessis D, Mazereeuw J, Charlesworth A, et al. Oral erythromycin therapy in epidermolysis bullosa simplex generalized severe. Br J Dermatol. 2015;173:563\u20134.","journal-title":"Br J Dermatol"},{"key":"940_CR19","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/j.jaad.2016.08.005","volume":"75","author":"C Chiaverini","year":"2016","unstructured":"Chiaverini C, Passeron T, Lacour JP. Topical timolol for chronic wounds in patients with junctional epidermolysis bullosa. J Am Acad Dermatol. 2016;75:e223\u20134.","journal-title":"J Am Acad Dermatol"},{"key":"940_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13023-016-0411-5","volume":"11","author":"C Chiaverini","year":"2016","unstructured":"Chiaverini C, Roger C, Fontas E, Bourrat E, Bourdon-Lanoy E, Labreze C, et al. Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial. Orphanet J Rare Dis. 2016;11:31.","journal-title":"Orphanet J Rare Dis"},{"key":"940_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/exd.13141","volume":"26","author":"O Bornert","year":"2017","unstructured":"Bornert O, Peking P, Bremer J, Koller U, van den Akker PC, Aartsma-Rus A, et al. RNA-based therapies for genodermatoses. Exp Dermatol. 2017;26:3\u201310.","journal-title":"Exp Dermatol"},{"key":"940_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.matbio.2017.12.010","volume":"71","author":"A Nystrom","year":"2018","unstructured":"Nystrom A, Bernasconi R, Bornert O. Therapies for genetic extracellular matrix diseases of the skin. Matrix Biol. 2018;71:330\u201347.","journal-title":"Matrix Biol"},{"key":"940_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jaad.2016.10.009","volume":"76","author":"ML Kerns","year":"2017","unstructured":"Kerns ML, Guss L, Fahey J, Cohen B, Hakim JM, Sung S, et al. Randomized, split-body, single-blinded clinical trial of topical broccoli sprout extract: assessing the feasibility of its use in keratin-based disorders. J Am Acad Dermatol. 2017;76:449\u201353.","journal-title":"J Am Acad Dermatol"},{"key":"940_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1046\/j.1365-2133.2004.05816.x","volume":"150","author":"M Weiner","year":"2004","unstructured":"Weiner M, Stein A, Cash S, de Leoz J, Fine JD. Tetracycline and epidermolysis bullosa simplex: a double-blind, placebo-controlled, crossover randomized clinical trial. Br J Dermatol. 2004;150:613\u20134.","journal-title":"Br J Dermatol"},{"key":"940_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1001\/archderm.136.3.424-a","volume":"136","author":"NK Veien","year":"2000","unstructured":"Veien NK, Buus SK. Treatment of epidermolysis bullosa simplex (EBS) with tetracycline. Arch Dermatol. 2000;136:424\u20135.","journal-title":"Arch Dermatol"},{"key":"940_CR26","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/archderm.135.8.997","volume":"135","author":"CR Retief","year":"1999","unstructured":"Retief CR, Malkinson FD, Pearson RW. Two familial cases of epidermolysis bullosa simplex successfully treated with tetracycline. Arch Dermatol. 1999;135:997\u20138.","journal-title":"Arch Dermatol"},{"key":"940_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/archdermatol.2008.546","volume":"145","author":"RJ Abitbol","year":"2009","unstructured":"Abitbol RJ, Zhou LH. Treatment of epidermolysis bullosa simplex, weber-Cockayne type, with botulinum toxin type a. Arch Dermatol. 2009;145:13\u20135.","journal-title":"Arch Dermatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0940-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0940-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0940-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T05:45:34Z","timestamp":1572587134000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0940-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["940"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0940-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2018,11,1]]},"assertion":[{"value":"17 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare that this work received all necessary ethical approvals and that patients involved all consented to participate. This study was reviewed and approved by Salzburg IRB; approval 415-E\/1619\/28\u20132016.DRKS. DRKS00005412. Registered 6 November 2013,","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Verena Wally and Johann W. Bauer own shares of the company Diaderm, which receives license payments from Castle Creek Pharma (CCP). CCP is conducting a Phase 2\/3 study with a diacerein-containing ointment (NCT03154333).Johann W. Bauer was holder of the EMA orphan drug designation on diacerein in epidermolysis bullosa.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"193"}}